Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects With Heart Failure and Reduced Ejection Fraction

NCT05855135 is registered in ClinicalTrials.gov with Impulse Dynamics as lead sponsor.

NCT NCT05855135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05855135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects With Heart Failure and Reduced Ejection Fraction
Lead sponsor
Impulse Dynamics
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 17, 2023
Completion date
July 31, 2027
Enrollment
300 (estimated)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, ccm therapy, heart failure, heart failure with reduced ejection fraction, implantable defibrillator user, ischemic cardiomyopathy, non-ischemic cardiomyopathy, sudden cardiac arrest, ventricular fibrillation, ventricular tachycardia